694 related articles for article (PubMed ID: 7573670)
1. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
2. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
Dorfman DM; Shahsafaei A; Chan JK
Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.
Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T
Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537
[TBL] [Abstract][Full Text] [Related]
4. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
[TBL] [Abstract][Full Text] [Related]
5. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
6. Relationship between structure and T-lymphocyte maturation in human thymomas. Enzyme histochemical and immunohistological studies.
Palestro G; Valente G; Novero D; Stramignoni D; Geuna M; Rosai J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 52(5):389-402. PubMed ID: 2883762
[TBL] [Abstract][Full Text] [Related]
7. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component.
Kodama T; Watanabe S; Sato Y; Shimosato Y; Miyazawa N
Am J Surg Pathol; 1986 Jan; 10(1):26-33. PubMed ID: 2420219
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: a clinicopathologic study.
Watanabe M; Yu SK; Sawafuji M; Kawamura M; Horinouchi H; Mukai M; Kobayashi K
Cancer; 2002 Jan; 94(1):240-4. PubMed ID: 11815982
[TBL] [Abstract][Full Text] [Related]
11. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component.
Sato Y; Watanabe S; Mukai K; Kodama T; Upton MP; Goto M; Shimosato Y
Am J Surg Pathol; 1986 Dec; 10(12):862-70. PubMed ID: 3789252
[TBL] [Abstract][Full Text] [Related]
14. The distribution of epithelial membrane antigen in thymic epithelial neoplasms.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1992 Oct; 70(8):2077-81. PubMed ID: 1394038
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins in normal thymus and thymic epithelial tumors.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
[TBL] [Abstract][Full Text] [Related]
16. Thymoma: an immunohistochemical study.
Chan WC; Zaatari GS; Tabei S; Bibb M; Brynes RK
Am J Clin Pathol; 1984 Aug; 82(2):160-6. PubMed ID: 6380266
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
Li H; Ren B; Yu S; Gao H; Sun PL
BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T cell maturity in thymic epithelial cell tumors from BUF/Mna spontaneous thymoma rats and BUF/Mna-Rnu/+ rats showing delayed thymomagenesis.
Inoue M; Matsuyama M; Shiono H; Honda O; Sumikawa H; Tomiyama N; Okumura M
Int J Clin Exp Pathol; 2010 Jun; 3(6):587-92. PubMed ID: 20661406
[TBL] [Abstract][Full Text] [Related]
20. Human thymomas: evidence of immunohistologically defined normal and abnormal microenvironmental differentiation.
Rouse RV; Weiss LM
Cell Immunol; 1988 Jan; 111(1):94-106. PubMed ID: 2448046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
